KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Common Equity (2016 - 2025)

Charles River Laboratories International has reported Common Equity over the past 17 years, most recently at $3.2 billion for Q4 2025.

  • Quarterly results put Common Equity at $3.2 billion for Q4 2025, down 8.72% from a year ago — trailing twelve months through Dec 2025 was $3.2 billion (down 8.72% YoY), and the annual figure for FY2025 was $3.2 billion, down 8.72%.
  • Common Equity for Q4 2025 was $3.2 billion at Charles River Laboratories International, down from $3.4 billion in the prior quarter.
  • Over the last five years, Common Equity for CRL hit a ceiling of $3.8 billion in Q3 2024 and a floor of $2.2 billion in Q1 2021.
  • Median Common Equity over the past 5 years was $3.2 billion (2025), compared with a mean of $3.1 billion.
  • Biggest five-year swings in Common Equity: soared 32.25% in 2021 and later dropped 12.23% in 2025.
  • Charles River Laboratories International's Common Equity stood at $2.5 billion in 2021, then rose by 17.41% to $3.0 billion in 2022, then grew by 20.84% to $3.6 billion in 2023, then dropped by 3.76% to $3.5 billion in 2024, then fell by 8.72% to $3.2 billion in 2025.
  • The last three reported values for Common Equity were $3.2 billion (Q4 2025), $3.4 billion (Q3 2025), and $3.4 billion (Q2 2025) per Business Quant data.